Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

263 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mutated ATP10B increases Parkinson's disease risk by compromising lysosomal glucosylceramide export.
Martin S, Smolders S, Van den Haute C, Heeman B, van Veen S, Crosiers D, Beletchi I, Verstraeten A, Gossye H, Gelders G, Pals P, Hamouda NN, Engelborghs S, Martin JJ, Eggermont J, De Deyn PP, Cras P, Baekelandt V, Vangheluwe P, Van Broeckhoven C; BELNEU consortium. Martin S, et al. Acta Neuropathol. 2020 Jun;139(6):1001-1024. doi: 10.1007/s00401-020-02145-7. Epub 2020 Mar 14. Acta Neuropathol. 2020. PMID: 32172343 Free PMC article.
Contribution of rare homozygous and compound heterozygous VPS13C missense mutations to dementia with Lewy bodies and Parkinson's disease.
Smolders S, Philtjens S, Crosiers D, Sieben A, Hens E, Heeman B, Van Mossevelde S, Pals P, Asselbergh B, Dos Santos Dias R, Vermeiren Y, Vandenberghe R, Engelborghs S, De Deyn PP, Martin JJ, Cras P, Annaert W, Van Broeckhoven C; BELNEU consortium. Smolders S, et al. Acta Neuropathol Commun. 2021 Feb 12;9(1):25. doi: 10.1186/s40478-021-01121-w. Acta Neuropathol Commun. 2021. PMID: 33579389 Free PMC article.
Effectiveness and safety of safinamide in routine clinical practice in a Belgian Parkinson's disease population: an open-label, levodopa add-on study.
Belgian Safinamide Study Group; Bergmans B, Bourgeois P, Cras P, Dethy S, De Klippel N, Franco G, Garraux G, Geens K, Jacquerye P, Jeanjean A, Supiot F, Van der Linden C, Krygier C. Belgian Safinamide Study Group, et al. Among authors: van der linden c. Acta Neurol Belg. 2023 Jun;123(3):939-947. doi: 10.1007/s13760-022-02100-1. Epub 2022 Oct 6. Acta Neurol Belg. 2023. PMID: 36201116 Free PMC article.
Intestinal levodopa infusion: the Belgian experience.
Pickut BA, van der Linden C, Dethy S, Van De Maele H, de Beyl DZ. Pickut BA, et al. Among authors: van de maele h, van der linden c. Neurol Sci. 2014 Jun;35(6):861-6. doi: 10.1007/s10072-013-1612-5. Epub 2013 Dec 31. Neurol Sci. 2014. PMID: 24379105
Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based review.
Volkmann J, Albanese A, Antonini A, Chaudhuri KR, Clarke CE, de Bie RM, Deuschl G, Eggert K, Houeto JL, Kulisevsky J, Nyholm D, Odin P, Østergaard K, Poewe W, Pollak P, Rabey JM, Rascol O, Ruzicka E, Samuel M, Speelman H, Sydow O, Valldeoriola F, van der Linden C, Oertel W. Volkmann J, et al. Among authors: van der linden c. J Neurol. 2013 Nov;260(11):2701-14. doi: 10.1007/s00415-012-6798-6. Epub 2013 Jan 5. J Neurol. 2013. PMID: 23287972 Free PMC article. Review.
Double-blind clinical trial of thalamic stimulation in patients with Tourette syndrome.
Ackermans L, Duits A, van der Linden C, Tijssen M, Schruers K, Temel Y, Kleijer M, Nederveen P, Bruggeman R, Tromp S, van Kranen-Mastenbroek V, Kingma H, Cath D, Visser-Vandewalle V. Ackermans L, et al. Among authors: van kranen mastenbroek v, van der linden c. Brain. 2011 Mar;134(Pt 3):832-44. doi: 10.1093/brain/awq380. Brain. 2011. PMID: 21354977 Clinical Trial.
263 results